SCHEMBL6284131

SCHEMBL6284131

CC(=O)N(Cc1cccc(Cl)c1)c1cncc(N2CCN(C(=O)OC(C)(C)C)CC2)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CKS1B P61024 2/20 0.44
SKP1 P63208 2/20 0.44
SKP2 Q13309 2/20 0.44
ADORA2A P29274 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.42
MAPK1 P28482 1/20 0.42
MAPT P10636 1/20 0.42
TP53 P04637 2/20 0.40
POLB P06746 1/20 0.40
RXFP1 Q9HBX9 1/20 0.40
HTR2A P28223 2/20 0.40
HTR2C P28335 2/20 0.40
HTR2B P41595 2/20 0.40
ACHE P22303 1/20 0.40
GPR119 Q8TDV5 1/20 0.39
CHRM4 P08173 1/20 0.39
ADRB1 P08588 1/20 0.39
HTR1A P08908 1/20 0.39
CHRM5 P08912 1/20 0.39
CHRM1 P11229 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL905862 0.83 HTR2C (0.56) TP53HTR2AHTR2CHTR2BCHRM4
SCHEMBL6284103 0.82 HTR2C (0.53) HTR2AHTR2CHTR2BCHRM4ADRB1
SCHEMBL6286362 0.80 HTR2A (0.63) CKS1BSKP1SKP2ADORA2ASMN1; SMN2
SCHEMBL6284124 0.80 ACHE (0.54) CKS1BSKP1SKP2ADORA2ASMN1; SMN2
SCHEMBL6284838 0.75 CKS1B (0.52) CKS1BSKP1SKP2ADORA2ASMN1; SMN2
SCHEMBL6285188 0.74 CKS1B (0.50) CKS1BSKP1SKP2ADORA2ASMN1; SMN2
SCHEMBL6278910 0.74 CKS1B (0.50) CKS1BSKP1SKP2ADORA2ASMN1; SMN2
SCHEMBL6286764 0.74 RIPK1 (0.42) SMN1; SMN2MAPTPOLBHTR2C
SCHEMBL6278772 0.73 CKS1B (0.47) CKS1BSKP1SKP2SMN1; SMN2MAPT
SCHEMBL1432444 0.72 CKS1B (0.56) CKS1BSKP1SKP2SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6894050-B2 5-HT receptor ligands and uses thereof PFIZER INC. (US) 2005-05-17 US disclosed
US-20050090503-A1 5-HT receptor ligands and uses thereof PFIZER INC 2005-04-28 US disclosed
US-20030125334-A1 5-HT receptor ligands and uses thereof CHIANG PHOEBE (US) 2003-07-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050090503-A1 5-HT receptor ligands and uses thereof HTR2A, HTR1A, HTR5A CKS1B 4756/4885SKP1 4844/4885SKP2 4456/4885
US-20030125334-A1 5-HT receptor ligands and uses thereof HTR1A, HTR2A, HTR5A CKS1B 4727/4885SKP1 4832/4885SKP2 4444/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.